REFERENCES
- Kazatchkine , M. D. and Fearon , D. T. 1990 . De.ciencies of Human Complement Receptors Type 1(CR1, CD35) and Type 2 (CR2, CD 21) . Immunodef. Rev. , 2 : 17 – 41 .
- Kumar , A. , Malaviya , A. N. and Srivastava , L. M. 1994 . Lowered Expression of C3b Receptor (CR1) on Erythrocytes of Rheumatoid Arthritis Patients . Immunobiology , 9 : 191 – 199 .
- Yoon , S. H. and Fearon , D. T. 1985 . Characterization of a Soluble Form of the C3b/ C4b Receptor (CR1) in Human Plasma . J. Immunol , 134 : 3332 – 3338 .
- Pascual , M. , Duchosal , M. A. and Steiger , G. 1993 . Circulating Soluble CR1 (CD35) Serum Levels in Diseases and Evidence for its Release by Human Leukocytes . J. Immunol , 151 : 1702 – 1711 .
- Di Bona , D. , Montalto , G. and Clemenza , L. 1998 . Soluble Complement Receptor Type 1 (sCR1) in Chronic Liver Diseases: Serum Levels at different Stages of Liver Diseases . Clin. Exp. Immunol , 114 : 102 – 105 .
- Crowther , J. R. 1995 . “ Methods ” . In Molecular Biology 42. ELISA Theory and Practice New Jersey : Humana Press, Inc. .